Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose prednisone added to methotrexate and hydroxychloroquine in early rheumatoid arthritis
ChiCTR1900026116Phase 4Completed
- Sponsor
- Jinhua Hospital of Zhejiang University
- Start
- Jun 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of prednisone, methotrexate and hydroxychloroquine in rheumatoid arthritis (RA) (2 arms), sponsored by Jinhua Hospital of Zhejiang University. Primary endpoints: DAS28 at 12 months and joint MRI at 12 months. Started Jun 2014; status: completed.
02
Drugs
prednisonemethotrexatehydroxychloroquine
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on ChiCTR1900026116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026116.